-
[Press Release] iNtRON identifies Prophage and Jamphage in the Pancrea..
31 May,2023 -
[Press Release] iNtRON confirms cancer-controlling effect of PHAGERIA..
05 April,2023 -
[Press Release] iNtRON has confirmed the efficacy of BAL200, a novel e..
27 January,2023 -
[Press Release] iNtRON is finalizing the SAL200 Tech Transfer
13 January,2023 -
[Press Release] iNtRON developed advanced bacteriophage engineering pl..
19 October,2022 -
[Press Release] iNtRON completes the sponsorship transfer process for ..
25 August,2022 -
[Press Release] iNtRON developed New CRISPR/Cas technology specific fo..
11 August,2022 -
[Press Release] iNtRON Confirms Efficacy of CDL200 Against CDI Clinica..
13 July,2022 -
[Press Release] iNtRON to Seek a New Clinical Partner for SAL200 Endol..
29 June,2022 -
[Press Release] iNtRON Completes GLP-TOX Studies of BAL200
08 June,2022
